Medscape18d
Use of Transdermal Fentanyl in Patients With Continuous Non-Malignant Pain
Transdermal analgesia was then started using a patch delivering fentanyl 25 µg/h. Mrs D. tolerated and responded well to treatment, although she occasionally complained of breakthrough pain for ...
Nasdaq9d
Nutriband Secures Patent for AVERSA™ Abuse-Deterrent Technology in 46 Countries, Plans FDA Filing for Fentanyl Patch in 2025
Nutriband Inc. has successfully patented its abuse-deterrent transdermal technology in 46 countries, including key markets like the U.S., Europe, and China. The company is planning to file for FDA ...
The Globe and Mail9d
Nutriband Extends Chinese Patent to Macao for its AVERSA™ Abuse Deterrent Transdermal Technology
AVERSA Fentanyl has the potential to be the world’s first abuse-deterrent opioid patch designed to deter the abuse and misuse and reduce the risk of accidental exposure of transdermal fentanyl patches ...
Nutriband Issues Letter to Shareholders
ORLANDO, Fla., Dec. 31, 2024 (GLOBE NEWSWIRE) -- Nutriband Inc. (NASDAQ: NTRB) (NASDAQ: NTRBW) today announced that CEO Gareth Sheridan has published a letter to shareholders highlighting the ...
Morningstar9d
Nutriband Extends Chinese Patent to Macao for its AVERSA™ Abuse Deterrent Transdermal Technology
AVERSA Fentanyl has the potential to be the world’s first abuse-deterrent opioid patch designed to deter the abuse and misuse and reduce the risk of accidental exposure of transdermal fentanyl ...
Nutriband Inc. Extends Chinese Patent to Macao for AVERSA™ Abuse Deterrent Transdermal Technology
Nutriband Inc., a company primarily focused on the development of prescription transdermal pharmaceutical products, recently disclosed its completion of registration requirements to extend its Chinese ...